Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Licensing deal for Penthrox in Australia

Jun 3, 2019Mark EdwardsNews

3 June 2019

ASX ANNOUNCEMENT

Licensing deal for Penthrox in Australia

Medical Developments International Limited (ASX: MVP) is delighted to announce it has reached agreement with Mundipharma Pty Ltd (Mundipharma) for the exclusive distribution rights of Penthrox® in Australia.

Mr. John Sharman, Chief Executive Officer of MVP, said: “This is an exciting deal for MVP because Mundipharma has a respected presence in the pain market with broad sales force coverage across Australia.  This presence in the field is expected to lead to impressive sales growth in the short to medium term, particularly within General Practitioner and Hospital channels.”

For the full announcement please click on the following link – ASX Announcement – Licensing deal for Penthrox in Australia

 

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter